<SEC-DOCUMENT>0001564590-20-055951-index.html : 20201202
<SEC-HEADER>0001564590-20-055951.hdr.sgml : 20201202
<ACCEPTANCE-DATETIME>20201202205721
ACCESSION NUMBER:		0001564590-20-055951
CONFORMED SUBMISSION TYPE:	S-1MEF
PUBLIC DOCUMENT COUNT:		4
<REFERENCE-462B>333-250074
FILED AS OF DATE:		20201202
DATE AS OF CHANGE:		20201202
EFFECTIVENESS DATE:		20201202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACHIEVE LIFE SCIENCES, INC.
		CENTRAL INDEX KEY:			0000949858
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				954343413
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1MEF
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251088
		FILM NUMBER:		201365445

	BUSINESS ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101
		BUSINESS PHONE:		425-686-1500

	MAIL ADDRESS:	
		STREET 1:		520 PIKE STREET
		STREET 2:		SUITE 2250
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98101

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ONCOGENEX PHARMACEUTICALS, INC.
		DATE OF NAME CHANGE:	20080821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SONUS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19950825
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1MEF
<SEQUENCE>1
<FILENAME>achv-s1mef.htm
<DESCRIPTION>S-1MEF
<TEXT>
Document 1 - file: achv-s1mef.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>achv-ex51_18.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: achv-ex51_18.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>achv-ex231_17.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: achv-ex231_17.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>gae3icbposvq000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: gae3icbposvq000001.jpg

</DOCUMENT>
</SEC-DOCUMENT>